Advanced Biomed (ADVB) Income Statement (2023 - 2026)
Income Statement report data from Dec 31, 2023 to Mar 31, 2026 for Advanced Biomed (ADVB).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|
Operating Expenses | |||||||||
Research And Development | 240K (+26.32%) | 190K (-20.83%) | 240K (-20.00%) | 300K (+36.36%) | 220K (+4.76%) | 210K (+16.67%) | 180K (-41.94%) | 310K (+63.16%) | 190K |
Selling General And Administrative | 280K (+33.33%) | 210K (-27.59%) | 290K (-78.68%) | 1.36M (+288.57%) | 350K (+400.00%) | 70K (-79.41%) | 340K (-20.93%) | 430K (-6.52%) | 460K |
Operating Expenses | 520K (+30.00%) | 400K (-23.08%) | 520K (-68.48%) | 1.65M (+189.47%) | 570K (+103.57%) | 280K (-46.15%) | 520K (-30.67%) | 750K (+15.38%) | 650K |
Depreciation And Amortization | 10K (0.00%) | 10K (-80.00%) | 50K (-75.00%) | 200K (+900.00%) | 20K (0.00%) | 20K (-80.00%) | 100K (+100.00%) | 50K (-16.67%) | 60K |
Operating Income | |||||||||
Ebit | -490.00K | 6.86M | -390.00K (-44.29%) | -700.00K (-49.28%) | -1.38M (+51.65%) | -910.00K (+237.04%) | -270.00K (-74.53%) | -1.06M (+606.67%) | -150.00K |
EBITDA | -480.00K | 6.87M | -340.00K (-32.00%) | -500.00K (-63.24%) | -1.36M (+52.81%) | -890.00K (+456.25%) | -160.00K (-84.16%) | -1.01M (+1022.22%) | -90.00K |
Other Income / Expenses | |||||||||
Interest Income | - | 10K | - | 10K | - | 20K | - | - | 20K |
Net Interest Income | - | 10K | - | 10K | - | 20K | - | - | 20K |
Other Non Operating Income | 30K (-25.00%) | 40K (-71.43%) | 140K | -260.00K (-58.73%) | -630.00K (+103.23%) | -310.00K | 250K | -310.00K | 490K |
Net Income | |||||||||
Income Before Tax | -490.00K | 7.00M | -390.00K (-68.03%) | -1.22M (+1.67%) | -1.20M (+106.90%) | -580.00K (+114.81%) | -270.00K (-74.53%) | -1.06M (+606.67%) | -150.00K |
Net Income From Continuing Operations | -490.00K | 6.86M | -390.00K (-44.29%) | -700.00K (-49.28%) | -1.38M (+51.65%) | -910.00K (+237.04%) | -270.00K (-74.53%) | -1.06M (+606.67%) | -150.00K |
Net Income | -490.00K | 6.86M | -390.00K (-44.29%) | -700.00K (-49.28%) | -1.38M (+51.65%) | -910.00K (+237.04%) | -270.00K (-74.53%) | -1.06M (+606.67%) | -150.00K |
Comprehensive Income Net Of Tax | -520.00K | 6.48M | -470.00K (-84.54%) | -3.04M (+126.87%) | -1.34M (+185.11%) | -470.00K (-17.54%) | -570.00K (-17.39%) | -690.00K (+13.11%) | -610.00K |